Close Menu
    GCC TabloidGCC Tabloid
    • Automotive

      Jaguar Type 01 electric GT debuts with 1,030 PS

      October 7, 2026

      Japan new car sales rise 1.8% in first half of 2026

      July 2, 2026

      Porsche reveals bespoke 911 GT3 RS in Macadamiametallic

      May 18, 2026

      Mercedes-Benz unveils electric C-Class in Seoul

      April 21, 2026

      2027 Mercedes-Benz S-Class adds DIGITAL LIGHT micro-LEDs

      January 30, 2026
    • Business

      AfDB backs Morocco reforms and climate resilience with €434.4m

      November 14, 2026

      DP World partner ATI wins 25-year Manila port renewal

      November 13, 2026

      ADB flags $264 billion yearly ASEAN infrastructure gap

      November 12, 2026

      Amin Adam questions how Ghana will fund $10bn New Economy

      November 11, 2026

      Samsung Electronics cash assets hit record 214.8 trillion won

      November 9, 2026
    • Entertainment

      Sony confirms God of War trilogy remake and PS5 prequel

      February 13, 2026

      Apple Arcade adds Jeopardy and NFL games in September update

      August 19, 2025

      Moscow hosts historic 47th international festival

      April 19, 2025

      Legal action against ‘Ketamine Queen,’ doctors in Perry overdose

      August 17, 2024

      Web3 leader Immutable rolls out $50M gaming rewards initiative

      April 27, 2024
    • Health

      Ebola cases top 11,200 as Africa CDC warns of record outbreak

      November 16, 2026

      Yellow fever kills 18 across nine African nations, WHO says

      November 7, 2026

      Dengue kills 173 in October as Bangladesh toll climbs to 418

      November 2, 2026

      Ebola deaths in DR Congo reach 5,340, fatality rate at 51.6%

      November 2, 2026

      Ebola death toll in DR Congo nears 4,900 as cases pass 10,000

      October 28, 2026
    • Lifestyle

      Adidas unveils Treadflow, a treadmill shoe innovation

      August 24, 2025

      U.S. Polo Assn.’s fall-winter 2024 line inspired by Salt Lake City

      September 20, 2024

      JP Morgan funds Fresha with $31 million for AI and robotics growth

      August 23, 2024

      Adidas, Highsnobiety debut limited-edition sneakers

      January 6, 2024

      Unraveling Starbucks’ phenomenon as a worldwide coffee powerhouse

      September 1, 2023
    • Luxury

      Global luxury market contracts for first time since Great Recession

      November 18, 2024

      Uncover the allure of Rolex Deepsea – luxury awaits.

      April 10, 2024

      Beyond timekeeping to the prestige of the Rolex Day-Date

      March 2, 2024

      Rare uncut emerald dazzles at Sharjah show

      February 1, 2024

      Porsche and Frauscher launch the electric 850 Fantom Air

      October 17, 2023
    • News

      Sheikh Mohamed receives Venezuela’s Delcy Rodríguez in Abu Dhabi

      November 17, 2026

      Sheikh Mohamed and Ramos-Horta talk trade, energy and ASEAN

      November 16, 2026

      Sheikh Mohamed receives Arab League chief Nabil Fahmy

      November 14, 2026

      Three nations launch carbon crediting initiative at COP31

      November 13, 2026

      Nigeria and EU seal readmission deal after decade of talks

      November 12, 2026
    • Sports

      Africa hosts first Olympic event as Dakar 2026 YOG begins

      October 30, 2026

      Messi ends Argentina career with 207 caps and 125 goals

      September 1, 2026

      FIA President meets with Hungarian PM and Czech President

      July 28, 2026

      Portugal fall to Spain as Ronaldo legacy closes

      July 7, 2026

      Brazil exits World Cup after Norway Round of 16 victory

      July 6, 2026
    • Technology

      MEAPMP Launches: Revamped Independent Ad-Tech & Premium Media Buying Across MEA

      November 3, 2026

      Sam Altman calls UAE most forward-looking country on AI

      November 3, 2026

      Apple iPhone Duo sets a new benchmark for foldable design

      November 2, 2026

      Apple brings Touch and PROLED XDR display to MacBook Pro

      October 29, 2026

      Integrated Identity Enters Global Top 0.1% with Rare 100/100 Google PageSpeed

      October 29, 2026
    • Travel

      Over 9 million visitors lift Tunisia tourism income 3.4%

      November 17, 2026

      Damascus becomes Air Arabia Dammam’s second foreign route

      November 17, 2026

      Türkiye aims to rank sixth in global tourism revenue

      October 21, 2026

      Air Arabia launches Sharjah flights to Amman City Airport

      October 9, 2026

      Air Arabia resumes daily Ras Al Khaimah Kozhikode service

      October 7, 2026
    GCC TabloidGCC Tabloid
    Home » PharmaResearch Launches REJURAN in Saudi Arabia, Expanding Presence Across the Middle East
    PR Newswire

    PharmaResearch Launches REJURAN in Saudi Arabia, Expanding Presence Across the Middle East

    September 18, 2026
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Official REJURAN launch events held in Riyadh and Jeddah, drawing approximately 400 local medical professionals and industry representatives

    SEOUL, South Korea, Sept. 18, 2026 /PRNewswire/ — PharmaResearch, the pharmaceutical company behind the globally renowned skin booster REJURAN, held official launch symposiums in Saudi Arabia from September 11 to 12, marking the start of its broader market expansion efforts in the country.

    REJURAN launch event held in Riyadh and Jeddah on September 11-12 (Photo courtesy of PharmaResearch)

    The two-day symposium was held consecutively in Riyadh, the capital of Saudi Arabia, and Jeddah, the country’s second-largest city. Approximately 400 local dermatologists, plastic surgeons and industry representatives attended the events, showing strong interest in PharmaResearch’s proprietary DOT™ PN technology and the clinical applications of REJURAN, which incorporates the technology.

    Saudi Arabia is one of the largest healthcare and aesthetics markets in the Middle East, with dermatology, plastic surgery and medical aesthetics industries growing rapidly, particularly in Riyadh and Jeddah. As demand for nonsurgical aesthetic procedures continues to rise, interest is expanding beyond treatments focused primarily on volume enhancement toward approaches that prioritize overall skin quality and regenerative aesthetics, with greater emphasis on the skin’s overall health.

    Following REJURAN’s entry into the United Arab Emirates in 2024, PharmaResearch obtained medical device approval for REJURAN in Saudi Arabia in February 2026 and began local distribution through a partner in May. Building on the official launch symposium, the company plans to accelerate market expansion and strengthen brand awareness among leading local physicians and clinics.

    The symposium introduced REJURAN’s PN-based mechanism of action and a range of clinical applications. Local physicians showed particular interest in treatment cases involving areas that require a more precise approach, including the eye area, as well as practical techniques based on real-world clinical experience. Korean medical experts also shared a range of treatment approaches applicable to daily clinical practice, including techniques designed with patient convenience in mind and combination treatment cases involving energy-based devices (EBDs).

    Going forward, PharmaResearch plans to expand its network of local key opinion leaders (KOLs) and continue strengthening physician education programs and clinically focused academic marketing initiatives. Building on the experience it has gained in the UAE, the company intends to develop Saudi Arabia into a key growth market within the Gulf Cooperation Council (GCC) region and use it as a base for the gradual expansion of its business into major markets across the Middle East and North Africa (MENA).

    “This symposium was meaningful in that it enabled us to more actively communicate the clinical value of REJURAN in Saudi Arabia’s high-potential medical aesthetics market while expanding our engagement with local physicians,” a PharmaResearch representative said. “We will continue to strengthen the credibility and competitiveness of REJURAN across key Middle Eastern markets through educational and academic initiatives that enhance physicians’ understanding of the product and their experience using it.”

    About PharmaResearch

    PharmaResearch is a pioneering South Korean biopharmaceutical company dedicated to enhancing quality of life through regenerative medicine. Its portfolio spans medicines, medical devices, cosmetics and health supplements, built around its core DOT™ PDRN and DOT™ PN technologies, which are protected by multiple patents. PharmaResearch is headquartered in Gangneung, South Korea.

    The company is behind REJURAN, its globally recognized PN-based skin booster available in more than 50 countries, and REJURAN COSMETICS, its premium derma-cosmetic brand.

    Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/pharmaresearch-launches-rejuran-in-saudi-arabia-expanding-presence-across-the-middle-east-302882962.html

    Related Posts

    Midea Showcases Full-Stack AIDC Cooling Solutions and Industry Insights at DCW Middle East 2026

    November 18, 2026

    Hansol Bio Expands Its Global Footprint with K-Beauty Manufacturing Expertise

    November 18, 2026

    Atain Appoints Jitendra Sindhwani (Jimpy) as Chief Executive Officer

    November 17, 2026

    Partnerships and Sponsorship Agreements Support Launch of Ajman Media Forum “THE SIGNAL 2026”

    November 17, 2026

    ALIF Holding Plans to Establish ALIF Terra for Arid-Land Agriculture and Land Rehabilitation

    November 17, 2026

    Getac’s New MX60 and MX60W Bring Mission-Critical Computing to Operators at the Tactical Edge

    November 17, 2026
    Latest News

    Over 9 million visitors lift Tunisia tourism income 3.4%

    November 17, 2026

    Damascus becomes Air Arabia Dammam’s second foreign route

    November 17, 2026

    Sheikh Mohamed receives Venezuela’s Delcy Rodríguez in Abu Dhabi

    November 17, 2026
    © 2026 GCC Tabloid | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.